Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29426 - 29450 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	ARHGEF10	9639	upregulated	decitabine results in increased expression of ARHGEF10 mRNA	8p23.3	A20985
Decitabine	Approved Investigational	ARL4D	379	upregulated	decitabine results in increased expression of ARL4D mRNA	17q21.31	A21917
Decitabine	Approved Investigational	ATF3	467	upregulated	decitabine results in increased expression of ATF3 mRNA	1q32.3	A21915
Decitabine	Approved Investigational	BAG2	9532	downregulated	decitabine results in decreased expression of BAG2 mRNA	6p12.1	A21913
Decitabine	Approved Investigational	BAK1	578	upregulated	decitabine results in increased expression of BAK1 mRNA	6p21.31	A21917
Decitabine	Approved Investigational	BCL2	596	downregulated	decitabine results in decreased expression of BCL2 mRNA	18q21.33	A21181
Decitabine	Approved Investigational	BCL2	596	upregulated	decitabine results in increased expression of BCL2 mRNA	18q21.33	A21918
Decitabine	Approved Investigational	BCL2L11	10018	upregulated	decitabine results in increased expression of BCL2L11 mRNA	2q13	A21926
Decitabine	Approved Investigational	BDNF	627	upregulated	decitabine results in increased expression of BDNF mRNA	11p14.1	A21919
Decitabine	Approved Investigational	BIRC5	332	downregulated	decitabine results in decreased expression of BIRC5 mRNA	17q25.3	A21913
Decitabine	Approved Investigational	BMP7	655	upregulated	decitabine results in increased expression of BMP7 mRNA	20q13.31	A21919 A21927
Decitabine	Approved Investigational	BNIP3	664	upregulated	decitabine results in increased expression of BNIP3 mRNA	10q26.3	A21928 A21919
Decitabine	Approved Investigational	BRF2	55290	upregulated	decitabine results in increased expression of BRF2 mRNA	8p11.23	A20985
Decitabine	Approved Investigational	BSN	8927	downregulated	decitabine results in decreased expression of BSN mRNA	3p21.31	A21913
Decitabine	Approved Investigational	BTG3	10950	upregulated	decitabine results in increased expression of BTG3 mRNA	21q21.1	A21929
Decitabine	Approved Investigational	C1RL	51279	upregulated	decitabine results in increased expression of C1RL mRNA	12p13.31	A20985
Decitabine	Approved Investigational	CA12	771	upregulated	decitabine results in increased expression of CA12 mRNA	15q22.2	A21915
Decitabine	Approved Investigational	CAMTA2	23125	upregulated	decitabine results in increased expression of CAMTA2 mRNA	17p13.2	A20985
Decitabine	Approved Investigational	CAPN3	825	downregulated	decitabine results in decreased expression of CAPN3 mRNA	15q15.1	A21930
Decitabine	Approved Investigational	CAPN5	726	downregulated	decitabine results in decreased expression of CAPN5 mRNA	11q13.5	A21913
Decitabine	Approved Investigational	CARHSP1	23589	upregulated	decitabine results in increased expression of CARHSP1 mRNA	16p13.2	A21917
Decitabine	Approved Investigational	CASP6	839	upregulated	decitabine results in increased expression of CASP6 mRNA	4q25	A21931
Decitabine	Approved Investigational	CASP8	841	upregulated	decitabine results in increased expression of CASP8 mRNA	2q33.1	A21932 A21933 A21934
Decitabine	Approved Investigational	CASZ1	54897	upregulated	decitabine results in increased expression of CASZ1 mRNA	1p36.22	A21935
Decitabine	Approved Investigational	CAV1	857	upregulated	decitabine results in increased expression of CAV1 mRNA	7q31.2	A21919

Displaying entries 29426 - 29450 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability